Follow
The FDA issues warning letters when a company breaks the FDA regulations. They usually send warning letters after FDA inspection and find big problems that can cause serious health issues to consumers.
Warning letters contain information for the company like recall of products from the market or stop the production of the product in question. They can also threaten legal action if the company doesn’t fix the problem.
How are 483 and warning letters different?
The FDA use two different documents to the companies for regulatory violation – the FDA 483 and warning letters. FDA 483s are issued after inspection of manufacturing facilities when violations are found that need to be fixed. A warning letter is sent when the FDA finds that a company has failed to address the identified earlier. Warning letters are for more serious violations that could impact the health of the consumer while the 483 is for less severe problems. If any company receives an FDA 483, it should act quickly to correct the problems. Failing to do so may result in receiving a warning letter.
Which One is More Serious – FDA 483 or Warning Letter?
FDA inspection highlights the regulatory violations and FDA issues form 483 and warning letters to address them. FDA 483s and warning letters are serious but there is a difference between both. FDA form 483 is issued to inform the company about the problems that inspectors observed during the investigation. 483s are not any warning or action to shut down the production but it is normal information to resolve the issues found during inspection.
On the other hand, warning letters are sent after the 483 when the observed violations are not fixed within the time frame. Warning letters are more serious and have a negative impact on the business and the company’s reputation. A warning letter leads to the product recall of the problematic product.
However, both FDA 483 and warning letters can have a significant impact on company operations and it is critical to address the problems promptly. Another key difference is the public disclosure. Warning letters are disclosed publicly while 483 are disclosed to company management. Companies should take both regulatory actions seriously. If timely actions are not taken, 483s don’t take time to become a warning letter.
